About Products Applications Case Studies Blog FAQ

Book a Demo

Interested in finding out more about the CellMaker? Simply complete the form below and a member of our team will contact you.

Sitemap

Landing Pages

bacteriophage
Book a demo – mammalian
KUL case study
Book a demo – phage
Mammalian Research – Pivotal Scientific
Mammalian research

Global Rows

Pages

Dual Regular Controller
FR
Sitemap
DE
Mammalian
Bacteriophage Amplification
Bioreactor Bags
Enclosures
Microbial
Distributors
Regular Controller
Plus Controller
Contact
About
FAQ
Applications
Products
Blog
Home
Privacy Policy

Posts

Using the CellMaker to manufacture bacteriophage: Interview with Manuel Garrido from TechnoPhage as featured in Capsid & Tail
Phages 2020: the highlights
3 Key Takeaways from the Bacteriophage Therapy Summit
Annual Meeting of Austrian Association of Molecular Life Sciences and Biotechnology: 21 – 23 September
Phages 2020: 9 & 10 September
LabDays: 2 & 3 September 2020
Bacteriophage Therapy Summit: 27 & 28 August 2020
Meet the Team: Adam Ostrowski
Remote installation now available
Case Study: Phage Amplification for Crop Protection with KU Leuven
Case Study: Hybridoma culture in the CellMaker: Practical production of monoclonal antibodies
Joint Meeting on Vascular Biology, Inflammation and Thrombosis 2020
Meet our USA distributor: nanoscaleLABS
Laborama 2020: 11 & 12 June 2020
CANCELLED: SY-Stem 2020: 25 - 27 March 2020
CellMaker Dual Regular Controller now available
Phage Futures Congress 2020: 5 - 6 February 2020
Distributor Days 2019
Biotechnology Company of the Year 2019
16th Annual bioProcessUK Conference 2019: 26 - 28 November 2019
Meet our distribution network
Phages in Grenoble: 8 - 9 October
Optimising bacteriophage amplification as seen in Capsid and Tail
DiaLabXpo: 24 – 26 September
Phage Futures Europe: 25 - 26 September
Case Study: Bacteriophage amplification results using the CellMaker
Welcome to our new website!
Case Study: Using the CellMaker to produce and increase expression levels of a protein in Pichia pastoris
Case Study: Efficiency of Salmonella enterica serovar Enteritidis bacteriophage amplification using the CellMaker single-use bioreactor system
What is a single-use airlift bioreactor?
A fresh new look for Cellexus

+44 (0)1382 666357
enquiries@cellexus.com

Testimonials

The CellMaker system has allowed us to grow in scale and to achieve higher productivity. Instead of scaling “out” by using several flasks, we can combine it all in one bag inside the bioreactor. In the 8L bioreactor we can easily get between 3 and 8 litres of phage lysate, and in the 50L bioreactor somewhere between 10 and 50 litres in one go, and with higher phage concentration per unit of volume. The CellMaker was the most cost-effective option on the market for a single-use system with temperature control. It is one of the least expensive I have heard about, and this goes for the bioreactor bags as well. When you balance the cost-benefit, the CellMaker is a good option for phage biotechs.

Dr. Manuel Garrido, Production Specialist, TechnoPhage

“We have found the CellMaker reliable, easy to use and invaluable in our antibody production process, with minimal labour required. Our qualified team likes working with this bioreactor, using the advantages of disposable technologies and its precise regulation of biochemical parameters (pH, pO2, temperature). At low-cost and with low labour, the CellMaker rapidly produces large quantities of high-quality antibodies with high specific activity. The CellMaker system is a vital part of the production process of our innovative and unique p53 antibodies.”

Dr Jean-Christophe Bourdon, Principal investigator, Head of p53 isoform research group, University of Dundee

We have found the CellMaker reliable, easy to use and invaluable in our Pharmaceutical processes. Our qualified team likes working with this bioreactor, using the advantages of disposable technologies. The CellMaker produces the quantity and quality of bacteriophage that we are looking for. The 4 CellMaker systems have become a vital part of a production process of our innovative BAFASAL® product.

Dr. Arkadiusz Wojtasik, Project Director, Proteon Pharmaceuticals S.A.

© Cellexus | Privacy Policy | Sitemap

Sign up to our newsletter:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.